Annual Cash & Cash Equivalents
$167.30 M
-$129.30 M-43.59%
December 31, 2023
Summary
- As of February 7, 2025, CTKB annual cash & cash equivalents is $167.30 million, with the most recent change of -$129.30 million (-43.59%) on December 31, 2023.
- During the last 3 years, CTKB annual cash & cash equivalents has risen by +$2.07 million (+1.25%).
- CTKB annual cash & cash equivalents is now -54.12% below its all-time high of $364.62 million, reached on December 31, 2021.
Performance
CTKB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$162.27 M
-$15.62 M-8.78%
September 30, 2024
Summary
- As of February 7, 2025, CTKB quarterly cash and cash equivalents is $162.27 million, with the most recent change of -$15.62 million (-8.78%) on September 30, 2024.
- Over the past year, CTKB quarterly cash and cash equivalents has dropped by -$1.36 million (-0.83%).
- CTKB quarterly cash and cash equivalents is now -56.93% below its all-time high of $376.77 million, reached on September 30, 2021.
Performance
CTKB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CTKB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -43.6% | -0.8% |
| 3 y3 years | +1.3% | +23.4% |
| 5 y5 years | +455.4% | +23.4% |
CTKB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.1% | at low | -55.5% | +25.3% |
| 5 y | 5-year | -54.1% | +455.4% | -56.9% | +25.3% |
| alltime | all time | -54.1% | +455.4% | -56.9% | +25.3% |
Cytek Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $162.27 M(-8.8%) |
| Jun 2024 | - | $177.89 M(+5.4%) |
| Mar 2024 | - | $168.79 M(+0.9%) |
| Dec 2023 | $167.30 M(-43.6%) | $167.30 M(+2.2%) |
| Sep 2023 | - | $163.63 M(+24.4%) |
| Jun 2023 | - | $131.54 M(+1.6%) |
| Mar 2023 | - | $129.48 M(-56.3%) |
| Dec 2022 | $296.60 M | $296.60 M(-13.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $341.52 M(-2.4%) |
| Jun 2022 | - | $349.89 M(-3.5%) |
| Mar 2022 | - | $362.51 M(-0.6%) |
| Dec 2021 | $364.62 M(+120.7%) | $364.62 M(-3.2%) |
| Sep 2021 | - | $376.77 M(+135.7%) |
| Jun 2021 | - | $159.85 M(-5.2%) |
| Mar 2021 | - | $168.58 M(+2.0%) |
| Dec 2020 | $165.23 M(+448.5%) | $165.23 M |
| Dec 2019 | $30.12 M | - |
FAQ
- What is Cytek Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cytek Biosciences?
- What is Cytek Biosciences annual cash & cash equivalents year-on-year change?
- What is Cytek Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cytek Biosciences?
- What is Cytek Biosciences quarterly cash and cash equivalents year-on-year change?
What is Cytek Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of CTKB is $167.30 M
What is the all time high annual cash & cash equivalents for Cytek Biosciences?
Cytek Biosciences all-time high annual cash & cash equivalents is $364.62 M
What is Cytek Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, CTKB annual cash & cash equivalents has changed by -$129.30 M (-43.59%)
What is Cytek Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CTKB is $162.27 M
What is the all time high quarterly cash and cash equivalents for Cytek Biosciences?
Cytek Biosciences all-time high quarterly cash and cash equivalents is $376.77 M
What is Cytek Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, CTKB quarterly cash and cash equivalents has changed by -$1.36 M (-0.83%)